XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 118,544 $ 345,209
Marketable securities 263,874 112,230
Accounts receivable, net 32,549 32,439
Prepaid expenses 14,824 18,752
Other current assets 6,848 10,196
Total current assets 436,639 518,826
Marketable securities 234,594 391,907
Accounts receivable, net 1,803 2,262
Property and equipment, net 140,906 131,547
Operating lease right-of-use assets 59,471 60,904
Restricted cash 2,030 2,030
Other assets 8,350 6,428
Total assets 883,793 1,113,904
Current liabilities    
Accounts payable 25,210 11,387
Accrued expenses and other current liabilities 44,462 76,111
Deferred revenue 5,903 3,333
Operating lease liabilities 3,608 1,752
Liability related to sale of future royalties 44,365 37,889
Total current liabilities 123,548 130,472
Operating lease liabilities 84,673 84,929
Liability related to sale of future royalties 103,084 133,460
Other liabilities 8,664 745
Total liabilities 319,969 349,606
Stockholders’ equity    
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at September 30, 2022 and December 31, 2021
Common stock; $0.0001 par value; 100,000 shares authorized at September 30, 2022 and December 31, 2021; 43,292 and 42,831 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 4 4
Additional paid-in capital 963,694 928,095
Accumulated other comprehensive loss (18,256) (2,569)
Accumulated deficit (381,618) (161,232)
Total stockholders’ equity 563,824 764,298
Total liabilities and stockholders’ equity $ 883,793 $ 1,113,904